Tenderwize
Retour à la recherche

Fentanyl medicines excluding matrix patches and tablets

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Dec 30, 2027 · 489 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Fentanyl (ATC: N02AB03 - außer Matrixpflaster und Tabletten)

58/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

58 / 100

Complexité

42 / 100

Facteurs de risque

The structured data says electronic submission is not allowed, but the XML text says signed contract documents may be s...

The structured deadline is 2027-12-30T23:00:00Z, while the XML notice shows an end date of 2027-12-31 00:00:00+01:00.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive rebate agreements for pharmaceutical products containing fentanyl.
  • Open-house model with uniform contract terms and equal access for all qualified applicants.
Afficher le résumé complet

This is an open-house style notice for non-exclusive rebate agreements for pharmaceutical products containing fentanyl (ATC N02AB03, excluding matrix patches and tablets) with AOK Sachsen-Anhalt. The structured data indicates one lot, no estimated contract value, and a 2-year maximum term. The notice states that qualified pharmaceutical companies may join at any time under identical conditions, with no individual negotiations. Submission is not allowed electronically in the structured data, but the XML text also mentions postal submission and email transmission of signed contract documents, creating an inconsistency that should be clarified.

Risques

The structured data says electronic submission is not allowed, but the XML text says signed contract documents may be s...

The structured deadline is 2027-12-30T23:00:00Z, while the XML notice shows an end date of 2027-12-31 00:00:00+01:00.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical company or a group of pharmaceutical companies.
  • The notice states that only companies meeting the participation requirements will be contracted.

Administrative

  • Participation documents must be requested and then completed and signed in full.

Acheteur

Localisation

Magdeburg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE258393558

Activité

Health

Lots (1)

LOT-0001

Fentanyl medicines excluding matrix patches and tablets

Open-house rebate agreement for finished medicinal products containing fentanyl (ATC N02AB03), excluding matrix patches and tablets. The lot is for non-exclusive contracts under uniform conditions; any qualified pharmaceutical company may join. The contract can start from 2026-03-01 at the earliest and ends on 2028-02-29 regardless of start date. The XML text also mentions that signed contract documents may be sent by post or by email with a qualified electronic signature.

SuppliesEU fundedElectronic submission

Localisation

DEE03, Germany

Durée

2 YEAR

Catégorie

Pharmaceutical products

Date limite

Deadline Dec 30, 2027

Détails de la procédure

Date de publication
16 Dec 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
840297-2025

Documents (1)

Appels d'offres similaires